Jan A Litwin Selected Research

Jan A Litwin Research Topics

Disease

6	Inflammation (Inflammations) 01/2020 - 06/2015
4	Chronic Renal Insufficiency 01/2020 - 01/2015
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2013
3	Leukemia 12/2019 - 07/2012
3	Neoplasms (Cancer) 07/2012 - 09/2010
2	Vascular Calcification 01/2020 - 01/2013
2	Atherosclerosis 01/2020 - 01/2008
2	Vascular Diseases (Vascular Disease) 01/2020 - 11/2019
2	Myeloid Leukemia (Leukemia, Myelocytic) 11/2018 - 01/2008
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2008
2	Nevus (Nevi) 07/2012 - 09/2010
2	Dysplastic Nevus Syndrome (Dysplastic Nevus) 07/2012 - 09/2010
2	Melanoma (Melanoma, Malignant) 07/2012 - 09/2010
1	Multiple Sclerosis 01/2023
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 09/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2020
1	Arteriovenous Fistula 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Aortic Valve Disease 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Skin Neoplasms (Skin Cancer) 07/2012
1	Carcinogenesis 09/2010
1	Adenoma (Adenomas) 01/2007
1	Leiomyoma (Uterine Fibroids) 05/2003

Drug/Important Bio-Agent (IBA)

2	OsteopontinIBA 01/2023 - 01/2019
2	Vx-11eIBA 09/2020 - 12/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2020 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2015
2	MineralsIBA 01/2020 - 06/2015
2	vosaroxinIBA 12/2019 - 11/2018
2	CollagenIBA 11/2019 - 01/2007
2	Histone Deacetylase InhibitorsIBA 04/2014 - 07/2012
2	CyclinsIBA 07/2012 - 09/2010
1	Immunoglobulin G (IgG)IBA 01/2023
1	AntibodiesIBA 01/2023
1	STA-21IBA 09/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2020
1	Mitogen-Activated Protein KinasesIBA 09/2020
1	AntioxidantsIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	GlycosaminoglycansIBA 11/2019
1	Proteoglycans (Proteoglycan)IBA 11/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019
1	TAK 733IBA 11/2018
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018
1	Fibroblast Growth Factor-23IBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	ThrombomodulinIBA 01/2018
1	C-Reactive ProteinIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	PTX3 proteinIBA 01/2017
1	LigandsIBA 01/2016
1	OsteoprotegerinIBA 01/2016
1	Advanced Glycation End ProductsIBA 01/2015
1	Vorinostat FDA Link 04/2014
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 04/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Cyclin AIBA 07/2012
1	trichostatin A (A 300)IBA 07/2012
1	theasinensin AIBA 07/2012
1	Etoposide (VP 16)FDA LinkGeneric 07/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2012
1	Cyclin D1IBA 09/2010
1	Proteins (Proteins, Gene)FDA Link 09/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2010
1	Cyclin D3IBA 09/2010
1	ApolipoproteinsIBA 01/2008
1	phorbolIBA 01/2008
1	Apolipoproteins E (ApoE)IBA 01/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2008
1	LDL Receptors (LDL Receptor)IBA 01/2008
1	Hematoxylin (Haematoxylon)IBA 01/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2007
1	Capsules (Microcapsules)IBA 05/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2003

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 01/2020 - 01/2018